F-star Therapeutics (NASDAQ:FSTX) Downgraded by Zacks Investment Research to Sell

F-star Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  F-star Therapeutics Downgraded by Zacks Investment Research on 10/18/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More F-star Therapeutics (NASDAQ:FSTX) Downgraded by Zacks Investment Research to Sell

F-star Therapeutics (NASDAQ:FSTX) Downgraded by Zacks Investment Research to Sell

F-star Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  F-star Therapeutics Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More F-star Therapeutics (NASDAQ:FSTX) Downgraded by Zacks Investment Research to Sell